Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11940-022-00704-9 http://scihub22266oqcxt.onion/10.1007/s11940-022-00704-9 35317303!8931180!35317303     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Treat+Options+Neurol 2022 ; 24 (1): 17-40 Nephropedia Template TP {{tp|p=35317303|t=2022. Headache as a Neurologic Manifestation of Systemic Disease |pdf=|usr=}}{{35317303}} gab.com Text Headache as a Neurologic Manifestation of Systemic Disease JO: Curr Treat Options Neurol http://www.kidney.de/pget.php?&tw=1&pmid=35317303 #FOAvip PURPOSE OF REVIEW: This is an update of headache attributed to systemic disease and current therapeutic strategies. Clinical scenarios are discussed. RECENT FINDINGS: The diagnosis of headache attributed to metabolic or systemic disorder appears in the Appendix of International Classification of Headache Disorders, Third Edition, and requires further evaluation and validation. However, recent studies characterizing headache appear in the literature. Specific treatment includes addressing underlying systemic disorders, managing concurrent primary headache, and treating comorbidities that may exacerbate headache. Evidence for specific treatment trials for headache as a symptom is lacking, including headaches post-COVID19 infection. Calcitonin gene-related peptide receptor antagonists and 5-HT(1F) receptor agonists are attractive options for migraine with vascular comorbidities, but long-term studies are needed. SUMMARY: Headache is commonly encountered as a manifestation or complication of systemic disease. Further research is needed to validate headache associated with systemic disorders and to determine optimal treatment strategies. Twit Text FOAVip Headache as a Neurologic Manifestation of Systemic Disease ????Curr Treat Options Neurol http://www.kidney.de/pget.php?&tw=1&pmid=35317303 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=35317303 #FOAvip English Wikipedia <ref>{{Cite pmid|35317303}}</ref> Headache as a Neurologic Manifestation of Systemic Disease #MMPMID35317303 Cocores AN; Monteith TS Curr Treat Options Neurol 2022[]; 24 (1): 17-40 PMID35317303show ga PURPOSE OF REVIEW: This is an update of headache attributed to systemic disease and current therapeutic strategies. Clinical scenarios are discussed. RECENT FINDINGS: The diagnosis of headache attributed to metabolic or systemic disorder appears in the Appendix of International Classification of Headache Disorders, Third Edition, and requires further evaluation and validation. However, recent studies characterizing headache appear in the literature. Specific treatment includes addressing underlying systemic disorders, managing concurrent primary headache, and treating comorbidities that may exacerbate headache. Evidence for specific treatment trials for headache as a symptom is lacking, including headaches post-COVID19 infection. Calcitonin gene-related peptide receptor antagonists and 5-HT(1F) receptor agonists are attractive options for migraine with vascular comorbidities, but long-term studies are needed. SUMMARY: Headache is commonly encountered as a manifestation or complication of systemic disease. Further research is needed to validate headache associated with systemic disorders and to determine optimal treatment strategies. äHeadache as a Neurologic Manifestation of Systemic Disease (epmc).pdf DeepDyve Pubget Overpricing